ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Treatment Termination Criteria for Necrotizing (Malignant) Otitis Externa

by Andy M. Courson, MD, Holenarasipur R. Vikram, MD, and David M. Barrs, MD • July 1, 2014

  • Tweet
  • Email
Print-Friendly Version

Trio Best PracticeBackground

The diagnosis of necrotizing, or “malignant,” otitis externa (NOE) is typically made by the clinical picture of a severe otitis externa, often in a diabetic or immunocompromised patient, with associated skull base soft tissue infection and osteomyelitis, as visualized on magnetic resonance (MR) or computed tomographic (CT) scanning. While treatment efficacy has improved since the condition was first described decades ago, NOE remains a severe infection with potential for significant morbidity and mortality. Bacterial NOE is ideally treated with at least six weeks of culture-directed systemic antibiotics, often with infectious disease consultation. Patients presenting with NOE frequently have been previously treated with oral or topical antibiotics, rendering cultures negative. In these cases, many clinicians empirically treat with antipseudomonal antibiotics. Longer therapy may be required with multidrug resistant strains of bacteria such as Pseudomonas aeruginosa, or with molds such as Aspergillus fumigatus. As NOE can mimic squamous cell carcinoma of the external ear canal on physical exam and CT scan, some clinicians biopsy granulation tissue when diagnosis is uncertain or if granulation tissue is present after six weeks of treatment. Once clinical exam and laboratory markers have normalized, the otolaryngologist faces the problem of how to determine if treatment has been adequate and can be discontinued with minimal risk of recurrence. As soft tissue involvement is expected to have resolved, the concern is for persistent osteomyelitis. Two questions are important: what is the appropriate duration of antibiotics and how can the clinician tell when the infection is resolved.

You Might Also Like

  • Ventilation Tubes in Otitis Media May Lower Quality of Life
  • Should Antibiotics Be Prescribed for Acute Otitis Media?
  • Biofilms Likely Play Key Role in Pediatric Otitis Media and Otorrhea
  • What is the Role of Tympanostomy Tubes in the Treatment of Recurrent Acute Otitis Media?
Explore This Issue
July 2014

Best Practice

Based on recommendations for the treatment of osteomyelitis, bacterial NOE should be treated with at least six weeks of antibiotics. Even with clinical resolution, there may be concern for residual infection in a surgically inaccessible skull base area. Imaging studies can therefore be considered. MRI, CT, and Tc99 cannot be used to document resolution as bone changes persist after disease resolution. Ga67 scintigraphy or 111In-labeled leukocyte scintigraphy combined with SPECT/CT can help differentiate healing bone from active infection. If these are positive, antimicrobial therapy is continued, and the scans can be repeated at two to four week intervals until normalization. No current evidence exists for the efficacy of FDG PET in imaging NOE, but the otolaryngologist should consider consultation with radiologists specialized in nuclear medicine as imaging modalities may change rapidly. Recurrence has been reported to be around 15% to 20%, so at least a six month follow-up for NOE with a low threshold for reimaging is ideal. Future research directed at determining the sensitivity and specificity of the various radiologicmodalities in identifying resolution of disease could help unify recommendations for when to terminate therapy for NOE. Read the full article in the Laryngoscope.

Filed Under: Otology/Neurotology, Practice Focus, TRIO Best Practices Tagged With: Necrotizing otitis externaIssue: July 2014

You Might Also Like:

  • Ventilation Tubes in Otitis Media May Lower Quality of Life
  • Should Antibiotics Be Prescribed for Acute Otitis Media?
  • Biofilms Likely Play Key Role in Pediatric Otitis Media and Otorrhea
  • What is the Role of Tympanostomy Tubes in the Treatment of Recurrent Acute Otitis Media?

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Did You Receive COVID-19 Relief? Here Are Reporting Considerations for 2021
    • Otolaryngology Experts Share Best Practices in Five Areas
    • How Climate Change May Be Affecting Sleep Patterns for Adults and Children
    • Laryngologists Discuss Tough Tracheostomy Choices During COVID-19 Era
    • Head and Neck Cancer: Experts Discuss How to Improve Surgery Quality and Value

Polls

Did you receive funding from the CARES Act or Paycheck Protection Program?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.